Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
NCT01305707, Phase 4, Terminated, Hospital Universitari de Bellvitge
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression | ClinicalTrials.gov |
| NCT number | NCT01305707 | ClinicalTrials.gov |
| Status | Terminated | ClinicalTrials.gov |
| Phases | Phase 4 | ClinicalTrials.gov |
| Enrollment | 104 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Hospital Universitari de Bellvitge | ClinicalTrials.gov |
| Conditions | Depression | ClinicalTrials.gov |
| Interventions | C-ECT, PHARMACOTHERAPY | ClinicalTrials.gov |
| First posted | 2011-03-01 | ClinicalTrials.gov |
| Last updated | 2015-08-31 | ClinicalTrials.gov |
Registered outcomes 12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Hamilton Depression Rating Scale 21 items (HDRS-21) | One year. HDRS will be assessed in each follow-up visit (weekly the first month, fortnightly the second and third month, monthly the following 6 months and quarterly at 12 and 15 months). | HDRS-21 will measure the relapse year in each group. Relapse will be defined as the reappearance of relevant symptoms after resolutin of the acute episode, measured by a scoring in HDRS-21 between 15-17 over two following measures or a HDRS\>18 score in a single measure. | ClinicalTrials.gov |
| Secondary | Mini-Mental State Examination (MMSE 35) | Basal, at 8 months and 12 months | Assessment of general cognitive status. | ClinicalTrials.gov |
| Secondary | UKU - Adverse effects rating scales | Every assessment (weekly, fortnightly, monthly and quarterly) till the month 15 of the follow-up. | Qualitiative measure of side effects in each treatment group. | ClinicalTrials.gov |
| Secondary | Demographical Data Memory (MEDABI-20) | Basal, at 8 months and 12 months | Descriptive measure of cogntive status. | ClinicalTrials.gov |
| Secondary | Rey Figure | Basal, at 8 months and 12 months | Measure of visual perception, concentration and memory. | ClinicalTrials.gov |
| Secondary | Trail Making Test A | Basal, at 8 months and 12 months | Measure of attention and cognitive flexibility. | ClinicalTrials.gov |
| Secondary | Trail Making Test B | Basal, at 8 months and 12 months | Measure of attention and cognitive flexibility. | ClinicalTrials.gov |
| Secondary | Stroop Test | Basal, at 8 months and 12 months | Measure of selective attention, cognitive flexibility and processing speed as well as executive function. | ClinicalTrials.gov |
| Secondary | Direct and inverse digits (WAIS, Weschler Adults Intelligence Sacle). | Basal | Measure of general intelligence and attention | ClinicalTrials.gov |
| Secondary | Vocabulary WAIS (Weschler Adults Intelligence Scale) | Basal | Measure of general intelligence | ClinicalTrials.gov |
| Secondary | Frequency Hospitalization Quotient | One year | Measure of number of hospitalization per year. | ClinicalTrials.gov |
| Secondary | Hospital Day Quotient (HDQ) | One year | Number of days hospitalized per year. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)